Tuberculosis (TB) is more than just a disease; it poses a global health challenge. Caused by *Mycobacterium tuberculosis*, it spreads easily and can severely impact health.

Since 2012, China has made incredible strides in its fight against TB. Reports show a 30% drop in TB incidence and mortality rates, significantly outpacing global averages.

China is at the forefront of TB innovation, with groundbreaking clinical trials for a new mRNA TB vaccine. This potential game-changer could greatly surpass existing vaccines in efficacy, offering hope for more effective TB prevention globally.

With a new national TB plan for 2024-2030, China aims to reduce incidence rates below 50 cases per 100,000 by 2025.

In a powerful message, Peng Liyuan urged the world to unite against TB. This reflects the understanding that health threats do not respect borders, and only through cooperation can we hope to eradicate diseases like TB on a global scale.

Despite progress, China faces significant challenges. High-prevalence areas still exist, and vaccine shortages limit efforts.

As China forges ahead with TB control, technological advancements and global cooperation are vital.